Nano-Cap New Millennium Growth Fund’s Xtant Medical Holdings XTNT Stock Holding History

Nano-Cap New Millennium Growth Fund’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$168K	Buy	400,000 +50,000	+14%	+$24K	0.13%	114
2026 Q1	$195K	Buy	350,000 +70,000	+25%	+$43.1K	0.18%	114
2025 Q4	$220K	Buy	+280,000	New	+$203K	0.19%	116

Other funds holding XTNT

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Nano-Cap New Millennium Growth Fund's XTNT Position: Q2 2026 in Review

Nano-Cap New Millennium Growth Fund increased its Xtant Medical Holdings (XTNT) stake by 14% in Q2 2026, buying an estimated $24K and bringing the position to 400,000 shares worth $168K. The position accounts for 0.13% of the portfolio, ranked #114.

Nano-Cap New Millennium Growth Fund first reported a position in XTNT in Q4 2025 and has held it in 3 quarters since. The position peaked at $220K in Q4 2025. 32 funds tracked by Wall St. Rank hold XTNT as of Q2 2026.

Nano-Cap New Millennium Growth Fund held 400,000 shares of Xtant Medical Holdings worth $168K as of Q2 2026.
Nano-Cap New Millennium Growth Fund bought 50,000 Xtant Medical Holdings shares in Q2 2026, an estimated $24K.
Xtant Medical Holdings made up 0.13% of Nano-Cap New Millennium Growth Fund's portfolio in Q2 2026, its #114 holding.
Nano-Cap New Millennium Growth Fund first reported a position in Xtant Medical Holdings in Q4 2025 and has held it in 3 quarters since.
Nano-Cap New Millennium Growth Fund's Xtant Medical Holdings position peaked at $220K in Q4 2025.
32 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2026.

Based on Nano-Cap New Millennium Growth Fund's 13F filing for Q2 2026, filed 14 Aug 2026.